Novel Algorithms and Tools for Computational Protein Design with Applications to Drug Resistance Prediction, Antibody Design, Peptide Inhibitor Design, and Protein Stability Prediction
Proteins are biological macromolecules made up of amino acids. Proteins range from enzymes to antibodies and perform their functions through a variety of mechanisms, including through protein-protein interactions (PPIs). Computational structure-based protein design (CSPD) seeks to design proteins toward some specific or novel function by changing the amino acid composition of a protein and modeling the effects. CSPD is a particularly challenging problem since the size of the search space grows exponentially with the number of amino acid positions included in each design. This challenge is most often encountered when considering large designs such as the re-design of a PPI. Herein, we discuss how to use CSPD to predict resistance mutations in the active site of the dihydrofolate reductase enzyme from methicillin-resistant Staphylococcus aureus and we investigate the accuracy of an existing CSPD suite of algorithms, osprey. We have also developed novel algorithms and tools within osprey to more efficiently and accurately predict the effects of mutations. We apply these various algorithms and tools to three systems toward a variety of goals: predicting the affect on stability of mutations in staphylococcal protein A (SpA), re-designing HIV-1 broadly neutralizing antibody PG9-RSH toward improved potency, and designing toward a peptide inhibitor of KRas:effector PPIs.
Computational protein design
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.
Rights for Collection: Duke Dissertations
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info
Showing items related by title, author, creator, and subject.
LKB1 Loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT. Kaufman, Jacob M; Amann, Joseph M; Park, Kyungho; Arasada, Rajeswara Rao; Li, Haotian; Shyr, Yu; Carbone, David P (Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014-06)Inactivation of serine/threonine kinase 11 (STK11 or LKB1) is common in lung cancer, and understanding the pathways and phenotypes altered as a consequence will aid the development of targeted therapeutic strategies. Gene ...
Amino acid permeases require COPII components and the ER resident membrane protein Shr3p for packaging into transport vesicles in vitro. Kuehn, MJ; Schekman, R; Ljungdahl, PO (J Cell Biol, 1996-11)In S. cerevisiae lacking SHR3, amino acid permeases specifically accumulate in membranes of the endoplasmic reticulum (ER) and fail to be transported to the plasma membrane. We examined the requirements of transport of the ...
Touhara, K; Hawes, BE; van Biesen, T; Lefkowitz, RJ (Proc Natl Acad Sci U S A, 1995-09-26)The mechanism of mitogen-activated protein (MAP) kinase activation by pertussis toxin-sensitive Gi-coupled receptors is known to involve the beta gamma subunits of heterotrimeric G proteins (G beta gamma), p21ras activation, ...